Premia Global Advisors’s Pfizer PFE Stock Holding History

Premia Global Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,289	Closed	-$414K	–	290
2019 Q1	$414K	Buy	+10,289	New	+$412K	0.42%	34
2018 Q2	–	Sell	-10,973	Closed	-$369K	–	330
2018 Q1	$369K	Buy	10,973 +126	+1%	+$4.33K	0.32%	41
2017 Q4	$371K	Buy	+10,847	New	+$370K	0.36%	43

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Premia Global Advisors's PFE Position: Q2 2019 in Review

Premia Global Advisors sold out of Pfizer (PFE) in Q2 2019, closing a stake of 10,289 shares — an estimated $414K sold.

Premia Global Advisors first reported a position in PFE in Q4 2017 and held it in 3 quarters. The position peaked at $414K in Q1 2019. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

Premia Global Advisors reported no remaining Pfizer position as of Q2 2019 after selling out during the quarter.
Premia Global Advisors sold 10,289 Pfizer shares in Q2 2019, an estimated $414K.
Premia Global Advisors first reported a position in Pfizer in Q4 2017 and held it in 3 quarters.
Premia Global Advisors's Pfizer position peaked at $414K in Q1 2019.
2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Premia Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.